Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models

Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models

Allogeneic stem cell transplantation (allo-SCT) has become an important treatment modality for patients with high-risk acute myeloid leukemia (AML) and is also under investigation for soft tissue sarcomas. The therapeutic success is still limited by minimal residual disease (MRD) status ultimately l...

Full description

Bibliographic Details
Main Authors: Rettinger, Eva, Meyer, Vida, Kreyenberg, Hermann, Volk, Andreas, Kuçi, Selim, Willasch, Andre, Koscielniak, Ewa, Fulda, Simone, Wels, Winfried S., Boenig, Halvard, Klingebiel, Thomas, Bader, Peter
Format: Online
Language:English
Published: Frontiers Research Foundation 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356002/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356002/

Similar Items